The global graves’ disease market is anticipated to grow at a considerable CAGR of 4.2% during the forecast period (2021-2027). The market growth is mainly driven by growing demand for graves’ disease treatment owing to the growing prevalence of thyroid disorder, rising iodine disorder, and technological advancement among others. As per the world health organization (WHO), around 20 million Americans suffer from thyroid diseases across the US. World health organization (WHO) along with the American Association of Clinical Endocrinologists (AACE) also had highlighted the fact that effective thyroid therapeutics for treatment are demanded to fight and win against this disease.
To Request a Sample of our Report on Graves’ Disease Market: https://www.omrglobal.com/request-sample/graves-disease-market
Additionally, favorable reimbursement policies with strategic initiatives for the treatment of Graves diseases are further augmenting the growth and development of the market. For instance, in January 2020, Horizon Therapeutics plc along with one of the oldest volunteer eye health organizations Prevent blindness had launched an initiative for encouraging and motivating people who are having graves’ diseases to focus on eye health as well. This was done in the awareness month of graves diseases to focus on eye health by recognizing the symptoms of a separate, but related disease called Thyroid Eye Disease (TED) as Up to half of people with Graves’ disease will develop TED so taking care of it is a must.
(Get 15% Discount on Buying this Report)
A full Report of Graves, Disease Market is Available at: https://www.omrglobal.com/industry-reports/graves-disease-market
Market Coverage
· The market number available for – 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
Segment Covered-
· By Diagnosis
· By Treatment
Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
· Competitive Landscape- GlaxoSmithKline plc, Abbott Laboratories, Pfizer Inc., Macleods Pharmaceuticals Ltd., and EpiVax, Inc.
Global Graves’ Disease Market Segment
By Diagnosis
· Ultrasound
· Imaging Tests
· Radioactive Iodine Uptake
· Blood Sample
By Treatment
· Antithyroid medication
· Radioactive iodine therapy
· Surgery
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
